CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 172 enrolled
Drug / intervention
Oxycodone 10mg oral +1 moredrug
Likely dose
Oxycodone 10mg oralfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03139240
NCT03139240Phase 4Completed
CompareCT.gov

Opioid Analgesia for MAB: A Randomized Controlled Trial

Oregon Health and Science University·interventional·Posted May 3, 2017·Updated Aug 28, 2019

In Brief

A Phase 4 clinical trial evaluating Oxycodone 10mg oral and Placebo for MAB and Pain. Completed, enrolled 172 participants across 1 site.

Detailed Summary

Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study will help future providers understand whether prescribing opioids are an important adjunct for pain control in women undergoing MAB.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMAB, Pain
CountriesUnited States
CollaboratorsSociety of Family Planning

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMay 3, 2017
Enrollment StartMay 1, 2017
Primary CompletionMay 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.2 years ago

Interventions

Oxycodone 10mg oraldrug

Oxycodone 10mg oral given for pain control in addition to standard of care medications in women undergoing medical abortion

Placeboother

Placebo given in addition to standard of care medications in women undergoing medical abortion